COVID-19 Vaccines Skipped Vital Safety Checks ‘Due to Time Constraints’, German Inquiry Told

Receiving little coverage in the mainstream/legacy media, Germany’s parliamentary COVID-19 inquiry has heard testimony from former Pfizer toxicologist Dr. Helmut Sterz alleging that key safety checks on mRNA vaccines were not completed before rollout due to time constraints. Sterz says that studies on carcinogenicity and reproductive toxicity were either not performed or did not meet standard requirements, with the result that the fast-track approval process used during the pandemic left important gaps in safety evaluation.

Sterz also raised concerns about pregnancy-related risks and broader safety monitoring. He told the inquiry that available studies were insufficient to reliably assess impacts on fertility, pregnancy, or early development, and suggested that post-marketing surveillance systems may significantly underreport adverse events. He further questioned whether the claimed benefits of the vaccine outweighed potential risks based on the data available at the time, pointing to early safety reports that he believes should have prompted stronger regulatory scrutiny.

Particularly worryingly, Sterz alleges that the vaccine used in mass production differed from that used in clinical trials, potentially introducing impurities such as bacterial DNA. Calling for independent, long-term safety studies and greater transparency, he warns that public trust depends on thorough investigation.

To read how a recent study documents hundreds of cancer cases linked to COVID-19 vaccination across multiple countries, see this article on our website.